Multicenter study evaluating target attainment of anti-Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients.
Tyler ChanasGabrielle GibsonElizabeth LangenstroerDavid J HerrmannThomas W CarverKaitlin M AlexanderSai Ho Jason ChuiLisa ReinMichael HaKaylee M MaynardKristen BambergMary M O'KeefeMarisa O'BrienMariela Cardona GonzalezBrandon HobbsMehrnaz PajoumandWilliam J PeppardPublished in: Pharmacotherapy (2024)
An EBV-based dosing strategy was associated with higher odds of achieving anti-Xa level within target range for enoxaparin VTE prophylaxis compared to BMI-based dosing and may be a preferred method for VTE prophylaxis in adult trauma patients.